{"title": "Onkologische Zweitmeinung: Welche Rolle die Komplement\u00e4rmedizin f\u00fcr die Patienten spielt", "author": "Witt; Claudia M", "url": "https://dx.doi.org/10.1159/000516878", "hostname": "doi.org", "description": "Abstract. Introduction: Oncological second opinions are becoming increasingly important given more complex treatment strategies, simultaneously more patients use complementary and alternative medicine (CAM), and many comprehensive cancer centers initiate integrative medicine programs. The present study focuses on analyzing the effects of a second opinion in relation to attitudes toward CAM. Methods: In this prospective study patients (n = 97) with a diagnosis of breast cancer or gynecological malignancies who had requested a second opinion received a questionnaire before and after the second opinion concerning their attitudes toward CAM. Results: The majority of patients had breast cancer (72.2%, n = 70). Only 6.2% (n = 6) stated that they had been informed about CAM by the doctors who treated them first, 21.6% (n = 21) had received information about it when seeking the second opinion. After the first opinion, 42.3% (n = 41) wanted to try CAM, the same proportion trusted orthodox medicine alone. After the second opinion, 24 patients (24.7%) wanted to try CAM, while 38.1% (n = 37) relied exclusively on orthodox medicine. There was a significant correlation between an increased patients\u2019 need for information and interest in CAM (p = 0.02). Conclusions: Today, aspects of CAM still are very often no part of oncological first and second opinions. This might hence lead to discouraging patients to try out CAM and therefore integrative medicine programs in comprehensive cancer centers might be problem-solving.", "sitename": "Karger Publishers", "date": "2021-06-10", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Abstract\nIntroduction: Oncological second opinions are becoming increasingly important given more complex treatment strategies, simultaneously more patients use complementary and alternative medicine (CAM), and many comprehensive cancer centers initiate integrative medicine programs. The present study focuses on analyzing the effects of a second opinion in relation to attitudes toward CAM. Methods: In this prospective study patients (n = 97) with a diagnosis of breast cancer or gynecological malignancies who had requested a second opinion received a questionnaire before and after the second opinion concerning their attitudes toward CAM. Results: The majority of patients had breast cancer (72.2%, n = 70). Only 6.2% (n = 6) stated that they had been informed about CAM by the doctors who treated them first, 21.6% (n = 21) had received information about it when seeking the second opinion. After the first opinion, 42.3% (n = 41) wanted to try CAM, the same proportion trusted orthodox medicine alone. After the second opinion, 24 patients (24.7%) wanted to try CAM, while 38.1% (n = 37) relied exclusively on orthodox medicine. There was a significant correlation between an increased patients\u2019 need for information and interest in CAM (p = 0.02). Conclusions: Today, aspects of CAM still are very often no part of oncological first and second opinions. This might hence lead to discouraging patients to try out CAM and therefore integrative medicine programs in comprehensive cancer centers might be problem-solving.\nAbstract aus Hack CC, Wasner S, Meyer J, H\u00e4berle L, Jud S, Hein A, Wunderle M, Emons J, Gass P, Fasching PA, Egloffstein S, Beckmann MW, Lux MP, Loehberg CR. Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center in Relation to Complementary and Alternative Medicine. Complement Med Res. 2020;27(6):431\u2013439.\nTransfer in die Praxis von Prof. Claudia M. Witt (Z\u00fcrich)\nHintergrund\nDas Angebot und die Nachfrage von onkologischen Zweitmeinungen haben in den letzten Jahren zugenommen und die Gr\u00fcnde daf\u00fcr sind vielf\u00e4ltig. Deshalb ist es wichtig ein besseres Verst\u00e4ndnis f\u00fcr Beweggr\u00fcnde und m\u00f6gliche Zusammenh\u00e4nge zu bekommen. Qualitative Studien erlauben zwar ein vertieftes Verst\u00e4ndnis einzelner Situationen und Zusammenh\u00e4nge, sind aber aufwendig in der Datenanalyse und wenig generalisierbar. Quantitative Studien in Form von Umfragen und prospektiven Beobachtungsstudien bieten den Vorteil entsprechende Evaluationen niedrigschwellig und kosteng\u00fcnstig in den Klinikalltag zu integrieren. Sie haben jedoch den Nachteil, dass die Generalisierbarkeit ihrer Ergebnisse und damit deren Aussagekraft von der Selektion der Teilnehmenden abh\u00e4ngt. Zudem lassen sich komplexere Sachverhalte meist nicht gut abbilden oder ben\u00f6tigen fortgeschrittene statistische Analysemethoden.\nAus dem Datensatz der Studie von Loehberg et al. k\u00f6nnen die Gr\u00fcnde, warum eine Zweitmeinung eingeholt wird, entnommen werden [\n[1](javascript:;)]. In der Studie zeigte sich, dass der Wunsch \u00abnichts unversucht zu lassen\u00bb (85%) und die \u00dcberzeugung, dass die Meinung von mehreren \u00c4rzten zu einer besseren Behandlung f\u00fchren w\u00fcrde (84%), h\u00e4ufige Gr\u00fcnde waren. 73% der Teilnehmenden gaben zudem an weitere Informationen zu ben\u00f6tigen.\nVorgehen und Ergebnisse der Studie\nIn der hier besprochenen Publikation geht es um Aspekte der Komplement\u00e4rmedizin. Eingeschlossen wurden in die zugrundeliegende prospektive Beobachtungsstudie Frauen mit Brustkrebs oder gyn\u00e4kologischen Tumoren, die zwischen Juni 2014 und September 2016 eine Zweitmeinung in der Frauenklinik des Universit\u00e4tsklinikums Erlangen bez\u00fcglich ihrer onkologischen Behandlung einholten. Vor dem Gespr\u00e4ch und 2 Monate nach dem Gespr\u00e4ch (Follow-Up) wurden die Patientinnen gebeten einen Fragebogen auszuf\u00fcllen. Von 488 Patientinnen, die eine Zweitmeinung einholten, waren 164 bereit an der Studie teilzunehmen und 97 haben auch den Follow-Up Fragebogen ausgef\u00fcllt. Die vorliegende Publikation bezieht sich auf die Daten dieser 97 Patientinnen, was ca. 20% der Patientinnen, die eine Zweitmeinung erhielten, entspricht. Die meisten Frauen (78%) wurden von ihren \u00c4rzten zuvor nicht \u00fcber Komplement\u00e4rmedizin informiert und nur 7% gaben an Nutzerinnen zu sein. Die Autoren diskutieren selbst, dass dies deutlich weniger als in anderen Erhebungen ist und ggf. der fr\u00fche Zeitpunkt nach Diagnose in der vorliegenden Studie eine Erkl\u00e4rung daf\u00fcr sein k\u00f6nnte. Das interessanteste Ergebnis ist jedoch, dass das Bed\u00fcrfnis Komplement\u00e4rmedizin nutzen zu wollen, sich nach dem Zweitmeinungsgespr\u00e4ch deutlich reduziert hat (von 42% der Teilnehmenden auf 25%).\nFazit f\u00fcr die Praxis\nF\u00fcr die Praxis ergeben sich aus der Publikation zwei Anregungen: Zum einen sollte das Thema Komplement\u00e4rmedizin in die onkologische Sprechstunde integriert werden, zumindest was die Information der Patientin betrifft. Es stehen seri\u00f6se Informationsquellen und Fortbildungen zur Verf\u00fcgung [\n[2](javascript:;)].\nZum andern l\u00e4sst sich vermuten, die Autoren haben es allerdings nicht explizit analysiert, dass sich der Wunsch \u00abnichts unversucht zu lassen\u00bb (h\u00e4ufigste Motivation f\u00fcr eine Zweitmeinung wie in der Publikation beschrieben) auch auf die Komplement\u00e4rmedizin erstreckt und das Bed\u00fcrfnis reduziert wird, wenn durch eine Zweitmeinung mehr Sicherheit bez\u00fcglich Diagnose und Therapie vermittelt wird.\nDisclosure Statement\nDie Autorin gibt keine Interessenskonflikte an.", "language": null, "image": "https://karger.silverchair-cdn.com/karger/content_public/journal/kko/issue/8/2/2/m_kko_8_n_2_cover.png?Expires=1761194810&Signature=OBTZW65~~nu6Tx-Hi6pZDp4RbvCDqVzfdRRQp9TwZaQM11rqn5NSKiXQspPC0tlyJixOXzpaEJnQu9x~hRbUNoTFwVOb5eEgJd1CZ1mJc69refwTEIwxzLb~a3pmBFTWCWi7csEhyHYsfoFweQP-bsl~Cu9DKNIbX~71fJORZXEpalAgXP8WPueI45DrvgDVmUjZTo7PahEjFx2XZWAvqem7m4y2CQSGaDQlJaEoHAEkLR7euS8TjvD8gtkxhidg3YRnMzLuARuxd-tvYeE1I92h3ZTDDPphcH6GwOSus5EYYFBKwWtD6jaY1JzX4TT-JRJg0kz5O1~bXhN-wxAcoA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA", "pagetype": "article", "links": ["#skipNav", "javascript:;", "/", "javascript:;", "javascript:;", "/pages/who-we-serve", "/pages/researchers", "/pages/authors", "/pages/reviewers", "/pages/healthcare-professionals", "/pages/patients", "/pages/librarians", "/pages/health-sciences-industry", "/pages/society", "/pages/agents-distributors-booksellers", "javascript:;", "/pages/what-we-offer", "/pages/journals", "/pages/online-collections", "/collections/subject-area", "/pages/books", "https://courses.karger.com/", "/pages/podcasts", "javascript:;", "/pages/what-we-solve", "/pages/accessing-knowledge", "/pages/presenting-knowledge", "/pages/applying-knowledge", "/pages/about-us", "javascript:;", "/pages/publish-with-us", "/pages/publish-your-paper", "/pages/calls-for-papers", "/pages/publication-services", "/pages/partner-publications", "javascript:;", "/pages/resources-for-you", "/pages/newsroom", "/pages/exhibitions-and-webinars", "/pages/fast-facts-titles", "https://experience.karger.com/", "https://thewaitingroom.karger.com/", "https://www.embarrassingproblems.com/", "https://nephrologyviewpoints.karger.com/", "javascript:;", "javascript:;", "/advanced-search", "https://karger.com/store/cart", "javascript:;", "https://karger.com/store/cart", "/my-account/register?siteId=1000131&returnUrl=%2fkko%2farticle%2f8%2f2%2f82%2f186831%2fOnkologische-Zweitmeinung-Welche-Rolle-die", "javascript:;", "//karger.com/kko", "javascript:;", "javascript:;", "/kko/search-results?fl_SiteID=1000003&page=1&f_ContentType=Journal+Articles", "/kko/issue-covers", "/pages/rights-and-permissions", "/kko/pages/fokus", "javascript:;", "/kko/pages/details", "/kko/pages/contact", "/kko/pages/editorial-board", "/kko/pages/guidelines", "/pages/rights-and-permissions", "/pages/advertising", "#", "/kko/issue/8/2", "/kko/issue/8/2", "javascript:;", null, "http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Claus R", "http://scholar.google.com/scholar?q=author:\"Claus R\"", "#9775218", "#9775232", "#9775244", "#9775246", "https://karger.com/kko/collection/37/Oncology", "javascript:;", null, "mailto:claudia.witt@uzh.ch", "/kko/search-results?f_AllAuthors=Claudia%c2%a0M.+Witt", "http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Witt C", "http://scholar.google.com/scholar?q=author:\"Witt C\"", "mailto:claudia.witt@uzh.ch", "https://doi.org/10.1159/000516878", "javascript:;", "javascript:;", "/kko/article-split/8/2/82/186831/Onkologische-Zweitmeinung-Welche-Rolle-die", "javascript:;", "javascript:;", "javascript:;", "javascript:;", "javascript:;", "javascript:;", "javascript:;", "javascript:;", "/kko/article-pdf/8/2/82/3061177/000516878.pdf", "javascript:;", "javascript:;", "javascript:;", "javascript:;", "javascript:;", "javascript:;", "https://s100.copyright.com/AppDispatchServlet?publisherName=KARGER&publication=2296-5386&title=Onkologische%20Zweitmeinung%3A%20Welche%20Rolle%20die%20Komplement%C3%A4rmedizin%20f%C3%BCr%20die%20Patienten%20spielt&publicationDate=2021-05-06&volumeNum=8&issueNum=2&author=Witt%2C%20Claudia%C2%A0M.&startPage=82&endPage=83&contentId=10.1159%2F000516878&oa=&copyright=Silverchair%20Publisher&orderBeanReset=True", "javascript:;", "javascript:;", "https://doi.org/10.1159/000516878", "/Citation/Download?resourceId=186831&resourceType=3&citationFormat=0", "/Citation/Download?resourceId=186831&resourceType=3&citationFormat=0", "/Citation/Download?resourceId=186831&resourceType=3&citationFormat=0", "/Citation/Download?resourceId=186831&resourceType=3&citationFormat=0", "/Citation/Download?resourceId=186831&resourceType=3&citationFormat=0", "/Citation/Download?resourceId=186831&resourceType=3&citationFormat=0", "/Citation/Download?resourceId=186831&resourceType=3&citationFormat=1", "/Citation/Download?resourceId=186831&resourceType=3&citationFormat=3", "/Citation/Download?resourceId=186831&resourceType=3&citationFormat=2", "javascript:;", "javascript:;", "/advanced-search", "/kko/search-results?qb={\"Keywords1\":\"Breast+cancer\"}", "/kko/search-results?qb={\"Keywords1\":\"Complementary+and+alternative+medicine\"}", "/kko/search-results?qb={\"Keywords1\":\"Gynecological+malignancies\"}", "/kko/search-results?qb={\"Keywords1\":\"Integrative+medicine\"}", "/kko/search-results?qb={\"Keywords1\":\"Oncological+center\"}", "/kko/search-results?qb={\"Keywords1\":\"Second+opinion\"}", null, "javascript:;", "javascript:;", "https://doi.org/10.1007/s00404-020-05525-2", "https://scholar.google.com/scholar_lookup?title=Analysis%20of%20motives%20and%20patient%20satisfaction%20in%20oncological%20second%20opinions%20provided%20by%20a%20certified%20university%20breast%20and%20gynecological%20cancer%20center&author=CR%20Loehberg&author=J%20Meyer&author=L%20H%C3%A4berle&author=CC%20Hack&author=S%20Jud&author=A%20Hein&publication_year=2020 May&journal=Arch%20Gynecol%20Obstet&volume=301&pages=1299-306", "http://dx.doi.org/10.1007/s00404-020-05525-2", "http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1007%2Fs00404-020-05525-2", "http://www.ncbi.nlm.nih.gov/pubmed/32274639", "https://scholar.google.com/scholar_lookup?title=Komplement%C3%A4rmedizin%20in%20der%20gyn%C3%A4kologisch-onkologischen%20Sprechstunde%3A%20Wie%20mache%20ich%20mich%20fit%20daf%C3%BCr%3F&author=CM%20Witt&author=T%20M%C3%BCller&publication_year=2020&journal=Der%20Gyn%C3%A4kologe&volume=&pages=", null, "javascript:;", null, "javascript:;", "javascript:;", "javascript:;", "http://scholar.google.com/scholar?q=link:https%3A%2F%2Fkarger.com%2Fkko%2Farticle%2F8%2F2%2F82%2F186831", "javascript:;", "javascript:;", "javascript:;", "/kko/article/10/3/173/862332/Spektrum-Onkologie-wissenswert-kompakt-anregend", "/kko/article/10/3/180/862333/Veranstaltungskalender", "/kko/article/10/3/154/862339/CLL-Therapien-Zeitlich-begrenzt-und-zielgerichtet", "/kko/article/10/3/156/862340/NSCLC-Faktoren-fur-individuelle", "/kko/article/10/3/158/862341/PharmaNews", "/cmr/article/27/6/431/78330/Analysis-of-Oncological-Second-Opinions-in-a", "/onk/article/33/10/547/245411/Mitomycin-C-in-Patients-with-Gynecological", "/brc/article/14/1/35/53558/Evaluating-the-Demand-for-Integrative-Medicine", "/brc/article/15/4/380/53922/Prevalence-and-Predictors-for-Nonuse-of", "/pages/contact-and-support", "/pages/information-and-downloads", "/pages/rights-and-permissions", "/pages/terms-and-conditions", "/pages/catalogue-and-pricing", "/pages/company", "/pages/people-and-organisation", "/pages/newsroom", "/pages/careers", "/pages/newsletters", "/pages/exhibitions-and-webinars", "/pages/regional-offices", "/pages/community-voice", "/pages/researchers", "/pages/authors", "/pages/reviewers", "/pages/healthcare-professionals", "/pages/patients", "/pages/librarians", "/pages/health-sciences-industry", "/pages/society", "/pages/agents-distributors-booksellers", "/pages/contact-and-support", "#", "https://www.facebook.com/KargerPublishers/", "https://www.linkedin.com/company/karger-publishers", "https://x.com/KargerPublisher", "https://www.youtube.com/channel/UCnpxr2XR2_ikKqYrdbajSAw", "/ImageLibrary/umbrella/WeChat_QRcode.jpg", "https://experience.karger.com", "/pages/privacy-policy", "/pages/terms-of-use", "/pages/imprint", "javascript:void(0);", "javascript:;", "javascript:;", "/sign-in?returnUrl=%2fkko%2farticle%2f8%2f2%2f82%2f186831%2fOnkologische-Zweitmeinung-Welche-Rolle-die", "/my-account/register?siteId=1000131&returnUrl=%2fkko%2farticle%2f8%2f2%2f82%2f186831%2fOnkologische-Zweitmeinung-Welche-Rolle-die", "javascript:;", "javascript:;"]}